Showing results (71-80 of 105) with videos related to
Sort By:
Pageof 11
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 20, 2012
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph nodeMichelle W Ma, Ratna C Medicherla, Meng Qian, et al.Journal of Translational Medicine|December 11, 2014
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapyDuane Moogk, Ines Pires da Silva, Michelle W Ma, et al.Journal of Translational Medicine|August 4, 2012
Serum microRNAs as biomarkers for recurrence in melanomaErica B Friedman, Shulian Shang, Eleazar Vega-Saenz de Miera, et al.Journal of Translational Medicine|November 26, 2008
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patientsJessie Z Yu, Melanie A Warycha, Paul J Christos, et al.Cancer Chemotherapy and Pharmacology|May 23, 2023
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanomaDrew W Rasco, Theresa Medina, Pippa Corrie, et al.Journal of the National Cancer Institute|June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to TherapyMichael Lattanzi, Yesung Lee, Danny Simpson, et al.Journal of Neuro-Oncology|June 6, 2022
Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?Assaf Berger, Kenneth Bernstein, Juan Diego Alzate, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced MelanomaPaul Johannet, Nicolas Coudray, Douglas M Donnelly, et al.Transplantation and Cellular Therapy|May 7, 2026
Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Advanced MelanomaLilit Karapetyan, Justin Moser, Barbara T Ma, et al.Science Translational Medicine|July 20, 2018
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanomaScott J Rodig, Daniel Gusenleitner, Donald G Jackson, et al.Pageof 11